These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 14087615)

  • 1. COMPLEMENT AS A MEDIATOR OF INFLAMMATION. ENHANCEMENT OF VASCULAR PERMEABILITY BY PURIFIED HUMAN C'1 ESTERASE.
    RATNOFF OD; LEPOW IH
    J Exp Med; 1963 Nov; 118(5):681-98. PubMed ID: 14087615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ENHANCEMENT OF VASCULAR PERMEABILITY BY MIXTURES OF C'1 ESTERASE AND NORMAL SERUM.
    SMINK RD; ABERNETHY RW; RATNOFF OD; LEPOW IH
    Proc Soc Exp Biol Med; 1964 Jun; 116():280-3. PubMed ID: 14193359
    [No Abstract]   [Full Text] [Related]  

  • 3. STUDIES ON HUMAN C'1-ESTERASE. II. FUNCTION OF PURIFIED C'1-ESTERASE IN THE HUMAN COMPLEMENT SYSTEM.
    HAINES AL; LEPOW IH
    J Immunol; 1964 Mar; 92():468-78. PubMed ID: 14131465
    [No Abstract]   [Full Text] [Related]  

  • 4. The conversion of C'IS to C'1 esterase by plasmin and trypsin.
    Ratnoff OD; Naff GB
    J Exp Med; 1967 Feb; 125(2):337-58. PubMed ID: 4225264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT.
    MUELLER-EBERHARD HJ; LEPOW IH
    J Exp Med; 1965 May; 121(5):819-33. PubMed ID: 14280442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor.
    Ratnoff OD; Pensky J; Ogston D; Naff GB
    J Exp Med; 1969 Feb; 129(2):315-31. PubMed ID: 4178758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of C'1 esterase on vascular permeability in man: studies in normal and complement-deficient individuals and in patients with hereditary angioneurotic edema.
    Klemperer MR; Donaldson VH; Rosen FS
    J Clin Invest; 1968 Mar; 47(3):604-11. PubMed ID: 4170149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of activation of C'1 esterase in hereditary angioneurotic edema plasma in vitro.
    Donaldson VH
    J Exp Med; 1968 Mar; 127(3):411-29. PubMed ID: 5299945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACTION OF COMPLEMENT IN HEREDITARY ANGIONEUROTIC EDEMA: THE ROLE OF C'1-ESTERASE.
    DONALDSON VH; ROSEN FS
    J Clin Invest; 1964 Nov; 43(11):2204-13. PubMed ID: 14223932
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on immune cellular injury. II. Functional role of C'1 esterase in immune cytotoxicity.
    LEPOW IH; ROSS A
    J Exp Med; 1960 Dec; 112(6):1107-20. PubMed ID: 13761024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STUDIES ON HUMAN C'1-ESTERASE. III. EFFECT OF RABBIT ANTI-C'1-ESTERASE ON ENZYMATIC AND COMPLEMENT ACTIVITIES.
    HAINES AL; LEPOW IH
    J Immunol; 1964 Mar; 92():479-90. PubMed ID: 14128992
    [No Abstract]   [Full Text] [Related]  

  • 12. Anaphylatoxin formation by purified human C'1 esterase.
    Dias da Silva W; Lepow IH
    J Immunol; 1965 Dec; 95(6):1080-9. PubMed ID: 4158798
    [No Abstract]   [Full Text] [Related]  

  • 13. Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3.
    da Silva WD; Eisele JW; Lepow IH
    J Exp Med; 1967 Dec; 126(6):1027-48. PubMed ID: 6069927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromatographic resolution of the first component of human complement into three activities.
    LEPOW IH; NAFF GB; TODD EW; PENSKY J; HINZ CF
    J Exp Med; 1963 Jun; 117(6):983-1008. PubMed ID: 13929797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement.
    Dias Da Silva W; Lepow IH
    J Exp Med; 1967 May; 125(5):921-46. PubMed ID: 4960742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. THE MACROMOLECULAR NATURE OF THE FIRST COMPONENT OF HUMAN COMPLEMENT.
    NAFF GB; PENSKY J; LEPOW IH
    J Exp Med; 1964 Apr; 119(4):593-613. PubMed ID: 14151101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STUDIES ON IMMUNE HUMAN HEMOLYSIS : II. THE DONATH-LANDSTEINER REACTION AS A MODEL SYSTEM FOR STUDYING THE MECHANISM OF ACTION OF COMPLEMENT AND THE ROLE OF C'1 AND C'1 ESTERASE.
    Hinz CF; Picken ME; Lepow IH
    J Exp Med; 1961 Jan; 113(1):193-218. PubMed ID: 19867184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STUDIES ON HUMAN C'1-ESTERASE. I. PURIFICATION AND ENZYMATIC PROPERTIES.
    HAINES AL; LEPOW IH
    J Immunol; 1964 Mar; 92():456-67. PubMed ID: 14128991
    [No Abstract]   [Full Text] [Related]  

  • 19. The enzymatic nature of C'1r. Conversion of C'1s to C'1 esterase and digestion of amino acid esters by C'1r.
    Naff GB; Ratnoff OS
    J Exp Med; 1968 Oct; 128(4):571-93. PubMed ID: 5675434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BIOLOGIC PROPERTIES OF POLYNUCLEOTIDES. VII. VASCULAR PERMEABILITY IN GUINEA PIG SKIN INDUCED BY POLYINOSINIC ACID.
    YACHNIN S; RUTHENBERG JM
    J Immunol; 1965 Jan; 94():12-7. PubMed ID: 14253510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.